Esophageal Cancer Clinical Trials in Chengdu
3 recruitingChengdu, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Esophageal CancerGastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca2,130 enrolled230 locationsNCT07431281
Recruiting
Phase 2
Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
Esophageal Cancer
Sichuan University68 enrolled1 locationNCT06403878
Recruiting
Phase 2
Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis
Esophageal CancerRadiation ToxicityEsophagitis
First Affiliated Hospital of Chengdu Medical College120 enrolled1 locationNCT06392971